Comment: This study shows interesting nuances, and different than what is often reported about it. It shows a clear ‘ceiling effect’ for iodine toxicity. The jump in subclinical pathology occurs as soon as we leave deficiency, with no significant difference in risk between ‘more than adequate’ and ‘excessive’ intake. Importantly, this toxicity appears strictly subclinical; […]
Comment: This is a fascinating review of a complex topic. The key clinical pearl here is the paradoxical finding that treatment-induced hypothyroidism (from TKIs/ICPis) often correlates with a favorable prognosis. It underscores the need to closely monitor thyroid function in these patients—not just as a side effect to be managed, but as a potential prognostic […]
Comment: The argument for a ‘window of opportunity’—where MHT might actually be neuroprotective if timed correctly—is compelling. However I remain cautious about broadly applying this as I tend to always consider the risk side of the equation with synthetic medications. The clinical management of Alzheimer’s disease (AD) prevention has long operated on the assumption that […]
Comment: This study presents a fascinating potential validation of the ‘on-target’ theory regarding lipid lowering and metabolic risk. The fact that genetically mimicking PCSK9 inhibition yields the same small increase in diabetes risk as mimicking statins implies a common downstream pathway—likely intracellular cholesterol accumulation in pancreatic beta cells. This means we should be looking at […]
Comment: While the finding that current MHT use is associated with concerning neuroimaging markers (accelerated Brain Age Gap, smaller hippocampus) compared to never-users warrants attention, there’s another important aspect – the lack of a statistically significant difference between specific formulations—namely oral versus non-oral (topical/vaginal) administration and estrogen-only versus combined HRT. It is becoming commonly accepted […]
Comment: This study is a potential critical piece of the puzzle because it bridges the gap between clinical observation and biological causality. We have known for some time from major clinical trials that statin therapy is associated with a slightly increased risk of developing type 2 diabetes. However, a lingering question has always been whether […]
Comment: The finding that 2 g/day of Grape Seed Extract (GSE) resulted in a 32.67% decrease in proteinuria and a decrease in creatinine are definitely clinically relevant outcomes. Furthermore, the significant improvements in antioxidant status (e.g., almost doubling Catalase activity) provide a plausible mechanism for the renal benefits. The major issue is the massive risk […]
Comment: I admit I love my UV, especially since moving back to New England – I have 3 apps on my phone so I know when it’s peak time to go outside. I also recognize that I have skin that tans and rarely burns, whereas other people don’t. It’s always been suspect to me that […]
Comment: I have used PRP for thumb joint pain and seen it been very helpful. This trial paints a very hopeful picture for the use of PRP for thumb CMC OA treatments. While we definitely need larger controlled trials to confirm these results, the initial data—specifically the high rate of moderate-to-excellent improvement—indicates that PRP could […]
Comment: This study reinforces a critical physiological reality often obscured by the aggressive ‘lower is better’ paradigm for lipids. While the cardiovascular benefits of managing dyslipidemia are well-established, we frequently ignore the risks of hypocholesterolemia, such as in this study. Beyond the diabetes signal identified here, very low LDL (<70 mg/dL) has been consistently linked […]
